Skip to content

Clinical trials

Phase 2/3 Psychotic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Phase 2/3 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20031
20042
20071
20101
20141
20151
20171
20191
20211
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Manhattan Psychiatric Center2
Abraham Reichenberg1
Bambino Gesù Hospital and Research Institute1
Clinic for Psychiatric Disorders, Dr Laza Lazarevic1
Melbourne Health1
Michigan State University1
Stanford University1
The University of Hong Kong1
US Department of Veterans Affairs1
University Hospital, Aker1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders16
Schizophrenia12
Bipolar Disorder2
Major Depressive Disorder2
22q11 Deletion Syndrome1
Affective Disorders, Psychotic1
Cognitive Dysfunction1
Depressive Disorder1
Diabetes Mellitus1
Disease1

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.